Keywords: Forest Labs, Grunenthalk, Analgesic drug, GRT 6005,, GRT 6006

Forest Labs gets rights to novel analgesic drug candidates from Grunenthal

Article | 08 December 2010

Print This

Family-owned German drugmaker Grunenthal has entered into a license agreement with the USA’s Forest Laboratories (NYSE: FRX) for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in